Russia has extensive experience in controlling brucellosis in large and small animals, based on systematic animal health and disease control measures, combined with the use of specifi c prophylaxis. Widespread application of the live brucellosis vaccine Brucella abortus strain 82 has led to a dramatic reduction in the prevalence of brucellosis. Among the distinctive properties of this vaccine are weak agglutinogenicity and high anti-epizootic effi cacy, which allow differentiation between infected animals and vaccinated animals, combined with protection against brucellosis infection. In this paper, the authors review brucellosis epidemiology, diagnostics, the application of vaccines and management procedures that allow the Russian Federation to reduce the overall prevalence of brucellosis.
Epidemiology
The former Soviet Union (FSU) and Russia have more than 40 years' experience in controlling large and small animal brucellosis through the implementation of complex, well-organised, routine animal health and anti-epizootic measures, based on the principle of controlling the epizootic process (12) . The systematic study of brucellosis in the FSU began in the 1930s when animal and human brucellosis were included in the group of infectious diseases that were subject to government regulation. Brucellosis control at that time was limited and focused only on preventing the transmission of infection to new farms or territories, by selective examination of cattle (mainly by the allergenic method), slaughter of serological reactors and animals that aborted, and animal health and hygiene procedures at farm facilities and within territories.
However, these measures did not lead to a decline in the number of brucellosis cases and the prevalence of cattle brucellosis in the FSU increased markedly. By 1952, the number of brucellosis-infected sites (individual farms, collective farms and/or larger geographical areas) had increased to 13,580, with over 280,000 detected cases of cattle brucellosis. Only after the development of the Brucella abortus strain 19 live vaccine, and its wide application across the FSU from 1953 till 1970, did the number of sites affected by cattle brucellosis decrease to 3,519 (53, 54) . The subsequent development and introduction of the Russian B. abortus strain 82 live vaccine into the national brucellosis control programme was the key factor for continued progress in reducing cattle brucellosis (2, 34, 35, 36) .
At present, brucellosis is still reported from all types of farms and domestic livestock in Russia, including strains of B. abortus, B. melitensis, B. suis and B. ovis. The choice of the diagnostic tests used under fi eld conditions is infl uenced by the properties of the pathogen, the route and dose of infection, the phase of the infection process and the species and age of the animal, among other factors. However, the serological tests available could not effectively detect infected animals during all phases of the infection, or were not suitable for use both on infected farms and in brucellosis-free areas. In recent times, new tests for brucellosis diagnostics, such as enzyme-linked immunosorbent assay (ELISA) tests based on monoclonal antibodies (28, 39, 52) , fl uorescent polarisation (22, 27) , and polymerase chain reaction (PCR) (49), were developed and introduced into veterinary use. The ELISA tests developed for cattle brucellosis include tests which can differentiate between antibodies to the smooth (S) and rough (R) forms of Brucella and antibodies to the S-LPS antigen of B. abortus, B. melitensis and B. suis (52) . As an alternative to bacteriological testing, the 'BRU-COM' test system was developed and introduced to detect Brucella by PCR. This test is highly sensitive and allows the detection of Brucella DNA when the sample contains an amount as small as ten colony-forming units (CFU) in physiological solutions, 25 CFU in cattle blood or milk, and 100 CFU in semen (48) .
Methods used to diagnose animal brucellosis in the Russian Federation are coordinated with the recommendations of the World Organisation for Animal Health (OIE).
Management
Eliminating brucellosis on cattle-breeding farms is the most effective way of reducing the economic costs associated with brucellosis infections. The most effective method on farms is to isolate any infected animals and remove them from the herd within two weeks of identifi cation of the pathogen.
Sheep or goats which abort should be removed immediately.
Only highly productive or pure-bred seropositive cattle can be kept in isolation. Because complete elimination of brucellosis from infected areas takes a long time (from three to fi ve or six years), all infected farms are registered and undergo systematic monitoring. Brucellosis-infected pastures are neutralised by not using them for two to three months; hay collected from infected sites is not used for two months; and water sources are not used for three months. Faecal material is heat-treated for two months. Contaminated areas from the sites of abortion or parturition are disinfected twice, with a mechanical cleaning after the fi rst disinfection. Contaminated bedding is burned. For other materials, such as equipment, shoes or clothes, disinfection procedures are used which employ 20% slack lime solution, 2% formaldehyde solution, 5% solution of soap-carbolic mixture, or 5% solution of phenolic creoline.
To prevent the transmission of brucellosis through animal products, the following measures are taken:
-the sale of milk and milk products from brucellosisinfected farms is forbidden -meat from brucellosis-infected animals is processed in meat-packing plants in such a way (mainly by meat heattreating) that the Brucella cells are inactivated -hides from brucellosis-infected animals are salted and stored for two months, and wool is held on the farms for two months or inactivated by a hot washing procedure.
Vaccination
Over 50 Brucella vaccine strains have been evaluated in the Russian Federation, with more than 30 of them reviewed by certifi cation boards ( four to fi ve months of age (10 11 CFU subcutaneously) and booster vaccinated at ten months of age. In brucellosis-free regions that border brucellosis-infected areas, cows are reimmunised after calving, and every two years thereafter. In brucellosis-infected areas, heifers are vaccinated twice with strain 82 and adult cows are re-vaccinated after calving and every one to two years thereafter, until brucellosis has been eliminated and the region shares no boundary with areas of infection.
More than 40 years of widespread vaccination with strain 82 in the Russian Federation has provided improved herd immunity in cattle and allowed earlier use of serological diagnostics after vaccination (three to six months after strain 82 vaccination versus two to three years after strain 19 vaccination); leading to the eradication of cattle brucellosis in many areas of Russia.
Another vaccine strain with weak agglutinogenic properties, which was used under fi eld conditions in the Russian Federation, was B. abortus strain 75/79-AB. This strain was isolated in 1979 from a seropositive cow that had been immunised twice (1974 and 1976) with strain 82 after in vitro passages in media, guinea pigs and heifers. Strain 75/79-AB is an RS-form strain. It was found to have satisfactory immunogenicity and was not abortogenic, which allowed the vaccination of pregnant cattle, irrespective of the stage of gestation, and also permitted serological testing within three months of immunisation (29, 30, 44) and 135,000 were vaccinated with strain 75/79-AB; and approximately 14,000 and 12,500 animals with strain 19. Over the last few years, agglutinogenic or weakly agglutinogenic adjuvant-vaccines have been evaluated (8, 13, 16, 21, 32) . A new strain, KB 17/100, was developed by selecting isolates based on cultural, morphological, biochemical and antigenic properties from a culture of the highly immunogenic B. abortus 104-M. KB 17/100 is in R-form, is stable after ten in vitro passages on nutrient media, has low residual virulence, and is adjuvanted in a 'water-in-oil' emulsion (14, 41, 43) .
Testing strain KB 17/100 in chronically infected cattle herds on 124 farms in the Saratov Oblast region suggested that this vaccine did not induce titres during diagnostic testing in naïve animals; did induce titres in cattle latently infected with brucellosis, allowing the rapid removal of infected cattle; is not abortogenic; and, as an inactivated vaccine, is ecologically safe. Despite their success to date in controlling brucellosis in cattle in the Russian Federation, researchers continue to work to develop new vaccines, and improve currently used vaccines. Using targeted genetic studies and evaluating the effects of various factors on Brucella cultures (bacteriophages, high temperature, ultraviolet rays, gamma radiation, ultrasound, antibiotics and others), new vaccine strains continue to be identifi ed and evaluated in in vivo studies.
Conclusion
Long experience in Russia has demonstrated that a system of organised animal health measures, combined with disease control steps, is the foundation stone in controlling animal brucellosis. The most effi cient means of control are brucellosis vaccines that induce weak serological titres. Offi cial brucellosis control programmes in Russia include the widespread vaccination of cattle with B. abortus strain 82 to reduce disease prevalence. Since strain 82 has weak agglutinogenic properties, it does not induce long-term titres in standard brucellosis tests, and thus allows the identifi cation of virulent fi eld strains of Brucella soon after vaccination (9) . As a result of the widespread use of strain 82 vaccine across the Russian Federation, the number of disease-infected sites has dramatically declined and many regions are now classifi ed as free of cattle brucellosis. In association with the decline in cattle brucellosis, there has also been a sharp decline in human brucellosis in Russia. The authors' experience is that optimising the use of strain 82 as part of a system of sanitary and control measures has been successful in reducing brucellosis in cattle.
Brucellose et santé publique vétérinaire : l'expérience de la Fédération de Russie La experiencia rusa de lucha contra la brucelosis como parte de la salud pública veterinaria
Résumé La Russie a une longue expérience dans la lutte contre la brucellose chez les grands et les petits ruminants, qui repose sur des mesures systématiques de santé animale et de contrôle de la maladie, associées à l'application de prophylaxies spécifi ques. La vaccination à grande échelle avec un vaccin utilisant la souche vivante 82 de Brucella abortus a considérablement réduit la prévalence de la brucellose. Les propriétés marquantes de ce vaccin sont sa faible agglutinogénicité et sa grande effi cacité anti-épizootique, qui permet la différenciation entre animaux infectés et animaux vaccinés (stratégie DIVA) tout en conférant une protection contre l'infection brucellique. Les auteurs font le point sur l'épidémiologie et le diagnostic de la brucellose, sur l'application de la vaccination et sur les procédures de gestion qui ont permis à la Fédération de Russie de réduire la prévalence globale de la brucellose. Resumen Rusia cuenta con gran experiencia en la lucha contra la brucelosis en grandes y pequeños rumiantes, con un método que combina una serie de medidas sistemáticas de sanidad animal y control de la enfermedad con el uso de profi laxis específi ca. La aplicación generalizada de la vacuna antibrucélica a base de organismos vivos de la cepa 82 de Brucella abortus ha deparado una espectacular reducción de la prevalencia de la enfermedad. Entre las propiedades características de esta vacuna están su escasa aglutinogenicidad y su gran efi cacia anti-epizoótica, lo que permite distinguir entre los animales infectados y los vacunados, además de conferir protección contra la infección. Los autores pasan revista a la epidemiología y el diagnóstico de la brucelosis, a la aplicación de vacunas y a los protocolos de gestión que han servido a la Federación de Rusia para reducir la prevalencia general de brucelosis.
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